Qiming Venture Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 40
- Investments
- 870
- Portfolio
- 347
- Exits
- 181
Qiming Venture Partners General Information
Description
Founded in 2006, Qiming Venture Partners is a venture capital firm headquartered in Shanghai, China with additional offices in Beijing, Suzhou, Hong Kong, Seattle, Boston, and San Francisco Bay Area. The firm prefers to invest in companies operating in the technology, media and entertainment, telecommunications, and healthcare
Contact Information
Website
www.qimingvc.com
Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Room 3906 Jinmao Tower
- 88 Century Boulevard
- Shanghai, 200121
- China
+86 021 0000 0000
Qiming Venture Partners Investments & Acquisitions (870)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| BlockVision | 07-Mar-2022 | Seed Round | Financial Software | Generating Revenue | ||
| 000000 00000000000 | 28-Feb-2022 | 00000 00000 | 0000 | Drug Discovery | Startup | |
| 000 000000000 | 16-Feb-2022 | 0000 00000 | General Purpose Semiconductors | Startup | ||
| 000 ( 000000000000 | 14-Feb-2022 | 00000 00000 | 0000 | Entertainment Software | Generating Revenue | |
| 00 000000000 | 13-Feb-2022 | 00000 00000 | 000.00 | Outcome Management (Healthcare) | Generating Revenue | 0000 00 |
| 00000 | 08-Feb-2022 | 00000 00000 | 00.000 | Media and Information Services (B2B) | Generating Revenue | |
| 00000 00000000000 | 28-Jan-2022 | 00000 00000 | 000.00 | Database Software | Startup | |
| 000000 | 24-Jan-2022 | 00000 00000 | Distributors/Wholesale | Generating Revenue | ||
| Ceptur Therapeutics | 19-Jan-2022 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | 00000 00000 00.0 |
| Eigencomm | 12-Jan-2022 | Later Stage VC | 00000 | General Purpose Semiconductors | Generating Revenue | 0000000 000 |
Qiming Venture Partners Exits (181)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Asieris Pharmaceuticals | 07-Jan-2022 | IPO | 00000 |
| 00000000 0-000000 | 14-Dec-2021 | 000 | 00000 |
| 000000000 000000 | 10-Dec-2021 | 000 | 000.00 |
| 00000 | 15-Nov-2021 | 000 | 00000 |
| 000000 00000000000 | 21-Oct-2021 | 000 | 00000 |
| 0000000 0000000000 | 13-Oct-2021 | 000 | 00000 |
| 0000000000 | 01-Oct-2021 | 000000000 00000000 | |
| 000000 00000000000 | 24-Sep-2021 | 000000000000000000 | 00000 |
| Broncus Medical | 13-Sep-2021 | IPO | 00000 |
| Roborock | 27-Aug-2021 | Secondary Transaction - Private |
Qiming Venture Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Qiming Venture Partners‘s full profile, request access.
Request a free trialQiming Venture Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialQiming Venture Partners Team (77)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Grace Lee | Partner, Group Chief Operating Officer & Chief Financial Officer | 0 | Hong Kong, Hong Kong | ||
| Nisa Bernice Leung | Managing Partner | 000 | 00 | 00 | Hong Kong, Hong Kong |
| Xubo Hu | Managing Partner | 000 | 00 | 00 | Shanghai, China |
| Ziping Kuang | Co-Founding Managing Partner | 00 | 00 | 00 | Shanghai, China |
| Robert Headley | Partner | Shanghai, China |
Qiming Venture Partners Co-Investors (729)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Sequoia Capital China | 26 | 0 | 00 |
|
|
| IDG Capital | 00 | 0 | 00 |
|
|
| Lilly Asia Ventures | 00 | 0 | 0 |
|
|
| GGV Capital | 00 | 0 | 00 |
|
|
| Hillhouse Capital Group | 00 | 0 | 0 |
|
|